Cargando…
Amyloid imaging for differential diagnosis of dementia: incremental value compared to clinical diagnosis and [(18)F]FDG PET
PURPOSE: Cerebral beta-amyloid and regional glucose metabolism assessed by positron emission tomography (PET) are used as diagnostic biomarkers for Alzheimer’s disease (AD). The present study validates the incremental diagnostic value of amyloid PET in addition to clinical diagnosis and [(18)F]FDG P...
Autores principales: | Hellwig, Sabine, Frings, Lars, Bormann, Tobias, Vach, Werner, Buchert, Ralph, Meyer, Philipp T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333717/ https://www.ncbi.nlm.nih.gov/pubmed/30094462 http://dx.doi.org/10.1007/s00259-018-4111-3 |
Ejemplares similares
-
Adding 11C-acetate to 18F-FDG at PET Examination Has an Incremental Value in the Diagnosis of Hepatocellular Carcinoma
por: Larsson, Patricia, et al.
Publicado: (2012) -
Brain and whole-body FDG-PET in diagnosis, treatment monitoring and long-term follow-up of primary CNS lymphoma
por: Maza, Sofiane, et al.
Publicado: (2013) -
Prognosis of conversion of mild cognitive impairment to Alzheimer's dementia by voxel-wise Cox regression based on FDG PET data
por: Sörensen, Arnd, et al.
Publicado: (2018) -
Differential diagnosis of parkinsonism: a head-to-head comparison of FDG PET and MIBG scintigraphy
por: Brumberg, Joachim, et al.
Publicado: (2020) -
More extensive hypometabolism and higher mortality risk in patients with right- than left-predominant neurodegeneration of the anterior temporal lobe
por: Frings, Lars, et al.
Publicado: (2023)